ArticleFrontiers in oncology2025

Case Report: A case of first-line treatment for rare ROS1 fusion mutation lung adenocarcinoma with entrectinib.

Yifan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.